Production (Stage)
Guardant Health, Inc.
GH
$38.00
$0.952.56%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 17.24% | 40.65% | -25.15% | -41.03% | 13.89% |
| Total Depreciation and Amortization | -4.44% | -3.81% | -3.98% | -0.08% | 3.55% |
| Total Amortization of Deferred Charges | -- | 0.31% | 0.16% | 0.31% | -- |
| Total Other Non-Cash Items | -31.08% | 17.14% | 1,048.20% | 512.64% | 121.15% |
| Change in Net Operating Assets | -396.66% | -104.41% | -45.38% | -166.56% | -56.78% |
| Cash from Operations | -107.00% | 18.06% | 34.36% | 0.01% | 59.32% |
| Capital Expenditure | 35.69% | -362.96% | -77.02% | 22.05% | 7.84% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 778.07% | -95.59% | -210.48% | 100.00% | -78.76% |
| Cash from Investing | 979.11% | -98.41% | -213.09% | 97.89% | -82.15% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 260.56% | -94.66% | -71.43% | -97.66% | 35.67% |
| Repurchase of Common Stock | -3,818.85% | -160.06% | 4.30% | 21.28% | -55.49% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4,824.12% | 111.03% | -100.46% | 97.94% | 1,527.78% |
| Cash from Financing | -6,124.39% | -103.24% | -175.78% | -98.46% | -25.76% |
| Foreign Exchange rate Adjustments | 167.93% | -264.56% | 461.22% | 33.15% | -598.16% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4,029.98% | -108.67% | -286.30% | -298.10% | -105.42% |